Compare ANDG & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDG | ICUI |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | United States | United States |
| Employees | N/A | 13000 |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.6B |
| IPO Year | 2025 | 1995 |
| Metric | ANDG | ICUI |
|---|---|---|
| Price | $48.67 | $183.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $31.17 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 363.0K | 318.0K |
| Earning Date | 03-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 1.96 |
| Revenue | $838,692,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $16.02 | N/A |
| Revenue Next Year | $13.67 | $4.46 |
| P/E Ratio | ★ N/A | $93.42 |
| Revenue Growth | ★ 14.64 | N/A |
| 52 Week Low | $18.12 | $112.50 |
| 52 Week High | $50.76 | $192.85 |
| Indicator | ANDG | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 68.31 |
| Support Level | $34.11 | $138.91 |
| Resistance Level | $48.32 | $192.85 |
| Average True Range (ATR) | 2.24 | 5.07 |
| MACD | -0.17 | 0.84 |
| Stochastic Oscillator | 61.95 | 67.01 |
Andersen Group Inc is a provider of independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services. The firm generates the key revenue from Private Client Services, which provide comprehensive tax and financial services for individuals and families, addressing complex client matters involving multigenerational wealth, charitable giving, and trust and estate planning.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.